CEO Interview

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) Advancing BioPharm Assets w Billion Dollar Markets

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) CEO Daniel Cohen shares update on LMLLF’s Advancing BioPharma pipeline assets addressing billion dollar markets opportunities in cancer, and glaucoma therapeutics. March 30, 2022 livestream     […]

CEO Interview

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) Billions Opportunity w/ autism psilocybin

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) CMO Marvin Hausman, M.D.: “Nova’s Psilocybin-based Therapeutics Showing Vast Potential for Autism and Other Neuroinflammatory Disorders” Update on  4/8/2022 livestream discussing clinical trial application […]

CEO Interview

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) Billion Dollar Markets W/ Multiple Shots on Goal3/9/2022 livestrea

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) Billion Dollar Markets W/ Multiple Shots on Goal 3/9/2022 livestream NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) Billion Dollar Markets W/ Multiple Shots on Goal 3/9/2022 […]

No Picture
Spotlight Stocks

Aterian, Inc. (NASDAQ: ATER) Q4 2021 Earnings Highlights

Aterian, Inc. (NASDAQ: ATER) Q4 2021 Earnings Highlights CEO Yaniv Sarig: “….Aterian is part of a new breed of technology-enabled consumer product companies. We focus on building, acquiring and partnering with e-commerce brands online. Aterian […]